• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Primary Central Nervous System Lymphoma

Primary Central Nervous System Lymphoma - 27 Studies Found

Not yet recruiting : Ketogenic Diet Adjunctive to HD-MTX Chemotherapy for Primary Central Nervous System Lymphoma
: Primary Central Nervous System Lymphoma
: 2016-11-29
:
  • Dietary Supplement: ketogenic diet

Completed : MT-R Followed by Autologous Stem Cells Transplantation in Newly-diagnosed Primary Central Nervous System Lymphoma
: Primary Central Nervous System Lymphoma
: 2015-03-01
: Drug: R-MT followed by auto-HSCT Four cycles of Induction therapy: Rituximab 375mg/m2 d1; Methotrexate 3
Completed : Study on Pembrolizumab for Recurrent Primary Central Nervous System Lymphoma (PCNSL)
: Primary Central Nervous System Lymphoma
: 2016-05-17
: Drug: pembrolizumab Pembrolizumab 200 mg every 3 weeks
Withdrawn : Antineoplaston Therapy in Treating Patients With Primary Central Nervous System Lymphoma
: Primary Central Nervous System Lymphoma
: 1999-11-01
:
  • Drug: antineoplaston A10
  • Drug: antineoplas

Withdrawn : a Phase II Study in Primary Central Nervous System Lymphoma
: Primary Central Nervous System Lymphoma
: 2007-04-02
:
  • Drug: Methotrexate
  • Drug: Methylprednisolon

Completed : PQR309 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma
: Primary Central Nervous System Lymphoma
: 2016-01-07
: Drug: PQR309 Oral PQR309, 80mg or 60mg daily or intermittent dosing
Not yet recruiting : PQR309 in Phase 2 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma
: Primary Central Nervous System Lymphoma
: 2017-04-10
: Drug: PQR309 Oral PQR309, 80mg or 60mg daily or intermittent dosing
Withdrawn : Study of Pemetrexed to Treat Recurrent or Progressive Primary Central Nervous System Lymphoma
: Primary Central Nervous System Lymphoma
: 2008-07-03
: Drug: Pemetrexed 500 mg/m2 given as an injection into a vein over 10 minutes once every 21 days until pr
Completed : Idarubicin Based Combined Modality Therapy in Primary CNS Lymphoma
: Primary Central Nervous System Lymphoma
: 2005-09-13
:
  • Drug: Idarubicin, Methotrexate, Filgrastim, intrathecal Ara-C

Completed : Temozolomide in Treatment of Patients With Primary Central Nervous System Lymphoma
: Primary CNS Lymphoma
: 2016-10-13
:
  • Drug: methotrexate
  • Drug: temozolomide

Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.